Insys Therapeutics misses by $0.12, misses on revenue

|About: Insys Therapeutics, Inc. (INSY)|By:, SA News Editor

Insys Therapeutics (NASDAQ:INSY): Q3 Non-GAAP EPS of -$0.37 misses by $0.12; GAAP EPS of -$0.41 misses by $0.14.

Revenue of $18.3M (-40.4% Y/Y) misses by $5.3M.

Shares -3.3%.

Press Release

Subscribe for full text news in your inbox